Skip to main content

Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.

Publication ,  Journal Article
Groeneweg, JA; Bhonsale, A; James, CA; te Riele, AS; Dooijes, D; Tichnell, C; Murray, B; Wiesfeld, ACP; Sawant, AC; Kassamali, B; Atsma, DE ...
Published in: Circ Cardiovasc Genet
June 2015

BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a progressive cardiomyopathy. We aimed to define long-term outcome in a transatlantic cohort of 1001 individuals. METHODS AND RESULTS: Clinical and genetic characteristics and follow-up data of ARVD/C index-patients (n=439, fulfilling of 2010 criteria in all) and family members (n=562) were assessed. Mutations were identified in 276 index-patients (63%). Index-patients presented predominantly with sustained ventricular arrhythmias (268; 61%). During a median follow-up of 7 years, 301 of the 416 index-patients presenting alive (72%) experienced sustained ventricular arrhythmias. Sudden cardiac death during follow-up occurred more frequently among index-patients without an implantable cardioverter-defibrillator (10/63, 16% versus 2/335, 0.6%). Overall, cardiac mortality and the need for cardiac transplantation were low (6% and 4%, respectively). Clinical characteristics and outcomes were similar in index-patients with and without mutations, as well as in those with familial and nonfamilial ARVD/C. ARVD/C was diagnosed in 207 family members (37%). Symptoms at first evaluation correlated with disease expression. Family members with mutations were more likely to meet Task Force Criteria for ARVD/C (40% versus 18%), experience sustained ventricular arrhythmias (11% versus 1%), and die from a cardiac cause (2% versus 0%) than family members without mutations. CONCLUSIONS: Long-term outcome was favorable in diagnosed and treated ARVD/C index-patients and family members. Outcome in index-patients was modulated by implantable cardioverter-defibrillator implantation, but not by mutation status and familial background of disease. One third of family members developed ARVD/C. Outcome in family members was determined by symptoms at first evaluation and mutations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Genet

DOI

EISSN

1942-3268

Publication Date

June 2015

Volume

8

Issue

3

Start / End Page

437 / 446

Location

United States

Related Subject Headings

  • gamma Catenin
  • Polymorphism, Genetic
  • Plakophilins
  • Middle Aged
  • Male
  • Kaplan-Meier Estimate
  • Humans
  • Follow-Up Studies
  • Female
  • Desmoplakins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Groeneweg, J. A., Bhonsale, A., James, C. A., te Riele, A. S., Dooijes, D., Tichnell, C., … Calkins, H. (2015). Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet, 8(3), 437–446. https://doi.org/10.1161/CIRCGENETICS.114.001003
Groeneweg, Judith A., Aditya Bhonsale, Cynthia A. James, Anneline S. te Riele, Dennis Dooijes, Crystal Tichnell, Brittney Murray, et al. “Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.Circ Cardiovasc Genet 8, no. 3 (June 2015): 437–46. https://doi.org/10.1161/CIRCGENETICS.114.001003.
Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, et al. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Jun;8(3):437–46.
Groeneweg, Judith A., et al. “Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.Circ Cardiovasc Genet, vol. 8, no. 3, June 2015, pp. 437–46. Pubmed, doi:10.1161/CIRCGENETICS.114.001003.
Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld ACP, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Jan Cramer M, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Jun;8(3):437–446.

Published In

Circ Cardiovasc Genet

DOI

EISSN

1942-3268

Publication Date

June 2015

Volume

8

Issue

3

Start / End Page

437 / 446

Location

United States

Related Subject Headings

  • gamma Catenin
  • Polymorphism, Genetic
  • Plakophilins
  • Middle Aged
  • Male
  • Kaplan-Meier Estimate
  • Humans
  • Follow-Up Studies
  • Female
  • Desmoplakins